Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.
Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy. Electronic address: mancandrea@libero.it.
Andrea
A
Mancuso
Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Chiara
C
Mazzarelli
Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Giovanni
G
Perricone
Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.
Claudio
C
Zavaglia
D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000627:therapeutic use*
D010671:Phenylurea Compounds; D009536:Niacinamide